Basic Research
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 21, 2006; 12(23): 3729-3735
Published online Jun 21, 2006. doi: 10.3748/wjg.v12.i23.3729
Table 1 Bacterial strains used in this study
Strain oroligonucleotidesRelevant characteristicsSource orPCR product
E. coli
TG1Cloning hostDSMZ1
D2241Non-pathogenic intestinal isolate, controlNCC2
Bifidobacterium
NCC362B. lactis, type strainNCC2
NCC2705B. longum, type strainNCC2
NCC251B. adolescentis, type strainNCC2
NCC189B. bifidumNCC2
S16B. bifidum, intestinal isolate from a breast-fed infant[57]
S17B. bifidum, intestinal isolate from a breast-fed infant[57]
E18B. infantis/longum, intestinal isolate from an adult[57]
MB226B. breve, type strainD. Matteuzzi
Table 2 Quantification of NF-κB-driven SEAP activity in the supernatants of HT-29 clone 34 cells
TreatmentRLU ± SD 1
None (untreated control)2 ± 1
HM2 ± 1
LPS5 ± 1
LPS + HM100 ± 6
Table 3 IL-8 protein in the supernatants of HT-29 cells (mean ± SD, n = 3)
TreatmentIL-8 [μg/L] 1
moi = 10moi = 100
None (untreated control)2 ± 1
LPS+HM36 ± 3
NCC2705/LPS+HM 130 ± 27 ± 3
S17/LPS+HM 17 ± 22 ± 0
Table 4 Real-time quantification of mRNA levels of several genes in HT-29 cells
TreatmentRelative mRNA level 1± SD of gene for
IL-8TNF-αCOX-2ICAM-1
LPS+HM (positive control)40.6 ± 17.437.4 ± 12.65.9 ± 1.728.0 ± 10.7
B. longum NCC2705/ LPS+HM 211.4 ± 1.1 a12.7 ± 1.8 a2.5 ± 1.612.2 ± 9.2
B. bifidum S17/ LPS+HM 23.5 ± 2.6 a2.9 ± 2.4 a1.4 ± 0.6 a2.0 ± 0.8  a